Featured Research

from universities, journals, and other organizations

Mayo Clinic Proves New Heart Muscle Cells Can Come From Bone Marrow

Date:
March 11, 2003
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers have proven for the first time that cells produced by the bone marrow can form new heart-muscle cells in adults, providing an important boost to research that could enable the body to replace heart muscle damaged by heart attack.

ROCHESTER, Minn. -- Mayo Clinic researchers have proven for the first time that cells produced by the bone marrow can form new heart-muscle cells in adults, providing an important boost to research that could enable the body to replace heart muscle damaged by heart attack. The findings are now available online and will be published tomorrow in Circulation: Journal of the American Heart Association.

"Until recently, the heart has been seen as an organ that cannot be healed," says Noel Caplice, M.D., the Mayo Clinic cardiologist who led the study. "Heart-attack damage to the myocardium, or heart muscle, was considered irreversible. This study points the way to a process that could lead to heart repair."

The researchers studied four female patients with leukemia who had survived 35 to 600 days after receiving bone-marrow transplants from male donors. Heart tissue samples were examined at autopsy using special staining techniques, which showed that a small portion of the heart-muscle cells, or cardiomyocytes, contained male genetic material and had therefore originated from the donor marrow. Of the more than 80,000 cell nuclei examined, about 1 in 425 (.23 percent) contained the y chromosome.

The study is important because it is the first confirmation that progenitor cells from outside the heart are capable of forming new heart muscle cells. "These progenitor cells are produced by the bone marrow and circulate in the blood," explains Dr. Caplice. "They are like stem cells in that they have potential to develop into various kinds of cells. Given the right biological signals, we have now shown they can become heart cells."

Dr. Caplice says the study has significant implications for future research. "Under normal conditions, with less than one percent of heart-muscle cells originating from these progenitor cells, they obviously are not adding much to the heart's pumping strength. But if we can determine the signaling mechanism that causes progenitor cells to develop into cardiomyocytes, we may be able to boost the response and induce more of them to proceed in that direction. A growth hormone delivered to the heart could perhaps lead to formation of new muscle around an area of scar tissue, so the heart could actually be healed after being damaged by heart attack. This study provides an important validation of the potential for this new line of research," Dr. Caplice concludes.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Proves New Heart Muscle Cells Can Come From Bone Marrow." ScienceDaily. ScienceDaily, 11 March 2003. <www.sciencedaily.com/releases/2003/03/030311074254.htm>.
Mayo Clinic. (2003, March 11). Mayo Clinic Proves New Heart Muscle Cells Can Come From Bone Marrow. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/03/030311074254.htm
Mayo Clinic. "Mayo Clinic Proves New Heart Muscle Cells Can Come From Bone Marrow." ScienceDaily. www.sciencedaily.com/releases/2003/03/030311074254.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins